HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 288/4/F748    most recent 00202.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Björnson, A. Articles by Sörensson, J. Search for Related Content PubMed PubMed Citation Articles by Björnson, A. Articles by Sörensson, J.

Primary human glomerular endothelial cells produce proteoglycans, and puromycin affects their posttranslational modification

¹Department of Nephrology and the ²Wallenberg Laboratory for Cardiovascular Research, Matrix and Proteoglycan Group, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden

Submitted 1 June 2004 ; accepted in final form 30 November 2004

This article describes the possible role of the endothelial cell-surface coat, containing proteoglycans (PGs) with connected glycosaminoglycans (GAGs), in maintaining glomerular permselectivity. Primary human glomerular endothelial cells (HGEC) in culture were treated with the nephrosis-inducing agent puromycin aminonucleoside (PAN). Analysis was made by TaqMan real-time PCR, Western blot analysis, and by metabolic labeling with [³⁵S]sulfate. The HGECs express several PGs: syndecan, versican, glypican, perlecan, decorin, and biglycan, which may contribute to the glomerular charge barrier. PAN treatment downregulated both the protein expression (by 25%) and the mRNA expression (by 37 ± 6%, P < 0.001, n = 8) of versican compared with control. Transferases important for chondroitin and heparan sulfate biosynthesis were also significantly downregulated by PAN, resulting in less sulfate groups, shorter GAG chains, and reduced PG net-negative charge. Moreover, analysis of the cell media after PAN treatment revealed a reduced content of [³⁵S]sulfate-labeled PGs (40% of control). We conclude that PAN may cause proteinuria by affecting the endothelial cell-surface layer and not only by disrupting the foot process arrangement of the podocytes. Thus the endothelium may be a more important component of the glomerular barrier than hitherto acknowledged.

glomerular basal membrane; glycosaminoglycan; heparan sulfate; chondroitin sulfate; glycocalyx; nephrotic syndrome

This article has been cited by other articles:

				B. Haraldsson, J. Nystrom, and W. M. Deen Properties of the Glomerular Barrier and Mechanisms of Proteinuria Physiol Rev, April 1, 2008; 88(2): 451 - 487. [Abstract] [Full Text] [PDF]

				A. Singh, S. C. Satchell, C. R. Neal, E. A. McKenzie, J. E. Tooke, and P. W. Mathieson Glomerular Endothelial Glycocalyx Constitutes a Barrier to Protein Permeability J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2885 - 2893. [Abstract] [Full Text] [PDF]

				M. Andersson, U. Nilsson, C. Hjalmarsson, B. Haraldsson, and J. S. Nystrom Mild renal ischemia-reperfusion reduces charge and size selectivity of the glomerular barrier Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1802 - F1809. [Abstract] [Full Text] [PDF]

				A. Bjornson Granqvist, K. Ebefors, M. A. Saleem, P. W. Mathieson, B. Haraldsson, and J. S. Nystrom Podocyte proteoglycan synthesis is involved in the development of nephrotic syndrome Am J Physiol Renal Physiol, October 1, 2006; 291(4): F722 - F730. [Abstract] [Full Text] [PDF]

				M. Jeansson and B. Haraldsson Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier Am J Physiol Renal Physiol, January 1, 2006; 290(1): F111 - F116. [Abstract] [Full Text] [PDF]